1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_ FORM 10-Q _ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended September 30,2024 orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF
2、 1934For the transition period from _ to _Commission File Number:1-10864 _ UnitedHealth Group Incorporated(Exact name of registrant as specified in its charter)_ Delaware41-1321939(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)9900 Bren Road East553436
3、55 New York Avenue NW20001Minnetonka,MinnesotaWashington,DC(Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)(800)328-5979(Registrants telephone number,including area code)_ Securities registered pursuant to Section 12(b)of the Act:Title of each clas
4、sTrading Symbol(s)Name of each exchange on which registeredCommon Stock,$.01 par valueUNHNew York Stock ExchangeIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or fo
5、r such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
6、 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller rep